TriSalus Life Sciences
$4.03
0
-$1.16-22.35% Thursday 04:00
Statistics
Day High
4.27
Day Low
4.03
52W High
-
52W Low
-
Volume
70
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
14MayExpected
Expected EPS
-0.158
Actual EPS
N/A
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TLSI.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
TriSalus Life Sciences, Inc., an immunotherapy company that develops and commercializes immunotherapies for the treatment of liver and pancreatic tumors. The company offers the TriNav Infusion System for hepatic arterial infusion of liver tumors; and the Pancreatic Retrograde Venous Infusion System for pancreatic tumors. It also develops SD-101, an investigational immunotherapeutic with pressure-enabled drug delivery technology for hepatocellular carcinoma, intrahepatic cholangiocarcinoma, uveal melanoma with liver metastases, pancreatic ductal adenocarcinoma with liver metastases, colorectal cancer with liver metastases, and primary pancreatic cancers. The company is based in Westminster, Colorado.
Show more...
CEO
ISIN
US89680M1018
Listings
0 Comments
Share your thoughts
FAQ
What is TriSalus Life Sciences stock price today?▼
The current price of TLSI.BOATS is $4.03 USD — it has decreased by -22.35% in the past 24 hours. Watch TriSalus Life Sciences stock price performance more closely on the chart.
What is TriSalus Life Sciences stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange TriSalus Life Sciences stocks are traded under the ticker TLSI.BOATS.
When is the next TriSalus Life Sciences earnings date?▼
TriSalus Life Sciences is going to release the next earnings report on May 14, 2026.
What were TriSalus Life Sciences earnings last quarter?▼
TLSI.BOATS earnings for the last quarter are -0.21 USD per share, whereas the estimation was -0.14 USD resulting in a -47.89% surprise. The estimated earnings for the next quarter are N/A USD per share.
When did TriSalus Life Sciences complete a stock split?▼
TriSalus Life Sciences has not had any recent stock splits.